0000899243-19-016201.txt : 20190610
0000899243-19-016201.hdr.sgml : 20190610
20190610164703
ACCESSION NUMBER: 0000899243-19-016201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190606
FILED AS OF DATE: 20190610
DATE AS OF CHANGE: 20190610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Audia James E
CENTRAL INDEX KEY: 0001746115
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 19889019
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-06
0
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0001746115
Audia James E
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
9.12
2019-06-06
4
A
0
13171
0.00
A
2029-06-05
Common Stock
13171
13171
D
This option was granted on June 6, 2019 and will vest as to all shares underlying the option on June 6, 2020, subject to continued service.
/s/ Karen Valentine, as attorney-in-fact for James E. Audia
2019-06-10